Literature DB >> 8223947

Dual activation of GABAA and glycine receptors by beta-alanine: inverse modulation by progesterone and 5 alpha-pregnan-3 alpha-ol-20-one.

F S Wu1, T T Gibbs, D H Farb.   

Abstract

The differential sensitivity of the glycine and GABAA receptors to modulation by progesterone and 5 alpha-pregnan-3 alpha-ol-20-one (5 alpha 3 alpha) was used to determine whether beta-alanine acts through its own receptor, or through the glycine and/or GABAA receptor(s). The response to beta-alanine resembles the glycine response as it is inhibited by strychnine (a competitive glycine antagonist) or progesterone (a negative modulator of the glycine response). Significantly, the response to beta-alanine also resembles the GABA response in that it is inhibited by 2-(carboxy-3'-propyl)-3-amino-6-paramethoxy-phenylpyridazinium+ ++ bromide (SR-95531; a competitive GABA antagonist) and potentiated by 5 alpha 3 alpha (a positive modulator of the GABA response). The efficacy of beta-alanine at the GABAA receptor is comparable to that of GABA. Similarly, the efficacy of beta-alanine at the glycine receptor is comparable to that of glycine. The greater potency of beta-alanine at the glycine receptor indicates that, if beta-alanine is a neurotransmitter, its effects are more likely to be mediated by glycine receptors than by GABAA receptors. However, activation of the GABAA receptor by beta-alanine may become important in the presence of steroid modulators such as progesterone or 5 alpha 3 alpha.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223947     DOI: 10.1016/0922-4106(93)90037-a

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism.

Authors:  Valerie W Hu; Tewarit Sarachana; Kyung Soon Kim; AnhThu Nguyen; Shreya Kulkarni; Mara E Steinberg; Truong Luu; Yinglei Lai; Norman H Lee
Journal:  Autism Res       Date:  2009-04       Impact factor: 5.216

Review 2.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

3.  Independence of and interactions between GABA-, glutamate-, and acetylcholine-activated Cl conductances in Aplysia neurons.

Authors:  J Kehoe; C Vulfius
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

4.  Multiple modes of GABAergic inhibition of rat cerebellar granule cells.

Authors:  David J Rossi; Martine Hamann; David Attwell
Journal:  J Physiol       Date:  2003-02-14       Impact factor: 5.182

5.  Interaction of androsterone and progesterone with inhibitory ligand-gated ion channels: a patch clamp study.

Authors:  Elke Ziegler; M Bodusch; Y Song; K Jahn; H Wolfes; S Steinlechner; R Dengler; J Bufler; K Krampfl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-25       Impact factor: 3.000

6.  Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia.

Authors:  Aza Shetewy; Kayoko Shimada-Takaura; Danielle Warner; Chian Ju Jong; Abu-Bakr Al Mehdi; Mikhail Alexeyev; Kyoko Takahashi; Stephen W Schaffer
Journal:  Mol Cell Biochem       Date:  2016-03-29       Impact factor: 3.396

7.  New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?

Authors:  André B P Van Kuilenburg; Alida E M Stroomer; Henk Van Lenthe; Nico G G M Abeling; Albert H Van Gennip
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

8.  Development of a FLIPR assay for the simultaneous identification of MrgD agonists and antagonists from a single screen.

Authors:  Seena K Ajit; Mark H Pausch; Jeffrey D Kennedy; Edward J Kaftan
Journal:  J Biomed Biotechnol       Date:  2010-09-14

9.  Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.

Authors:  Jian-jun Chen; Zhao Liu; Song-hua Fan; De-yu Yang; Peng Zheng; Wei-hua Shao; Zhi-guo Qi; Xue-jiao Xu; Qi Li; Jun Mu; Yong-tao Yang; Peng Xie
Journal:  Sci Rep       Date:  2014-07-28       Impact factor: 4.379

10.  Identification of physiologically active substances as novel ligands for MRGPRD.

Authors:  Makiko Uno; Satoko Nishimura; Keisuke Fukuchi; Yasuyuki Kaneta; Yoko Oda; Hironobu Komori; Shigeki Takeda; Tatsuya Haga; Toshinori Agatsuma; Futoshi Nara
Journal:  J Biomed Biotechnol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.